Biotech

King & Spalding Adds Top Deals Lawyer Judy O'Brien

REDWOOD SHORES, CA: ...

MDxHealth Is Continually Improving Their Subscribers Experience

LIEGE, BELGIUM: ...

Theratechnologies to Host Conference Call

MONTREAL, QUEBEC: ...

Stem Cell Therapeutics Announces Admission to Centre for Commercialization of Regenerative Medicine (CCRM) Consortium

TORONTO, ONTARIO: - Company enrolls two additional patients into Traumatic Brain Injury Trial - ...

TSRL, Inc. Reaches a Key Milestone With Pre-IND Meeting

ANN ARBOR, MI: ...

West to Host Third Quarter 2012 Conference Call

LIONVILLE, PA: ...

Warnex to Sell its Bioanalytical Services Division

LAVAL, QUEBEC: ...

The Medicines Company Reports Third Quarter 2012 Financial Results

PARSIPPANY, NJ: Growth Continues and Accelerated Research and Development Results in Completion of CHAMPION PHOENIX and SOLO I Phase 3 Clinical Trials ...

Orion Receives Positive Phase II Study Results of a New Levodopa Product for Parkinson's Disease

ESPOO, FINLAND: ...

Helix BioPharma Corp. Announces First Patient Enrolled and First Dose Administered in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47

AURORA, ON: ...